Price T Rowe Associates Inc Charles River Laboratories International, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 172,906 shares of CRL stock, worth $32.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

172,906

Previous 640,985 73.02%

Holding current value

$32.5 Million

Previous $132 Million 74.28%

% of portfolio

0.0%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $88 Million - $115 Million	-468,079 Reduced 73.02%	172,906 $34.1 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $141 Million - $183 Million	-681,469 Reduced 51.53%	640,985 $132 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $24.6 Million - $33 Million	-120,721 Reduced 8.36%	1,322,454 $358 Million
Q4 2023 Feb 14, 2024	SELL	$164.52 - $238.84 $39.1 Million - $56.7 Million	-237,498 Reduced 14.13%	1,443,175 $341 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $159 Million - $178 Million	-815,821 Reduced 32.68%	1,680,673 $329 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $1.8 Million - $2.06 Million	-9,799 Reduced 0.39%	2,496,494 $525 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $125 Million - $170 Million	653,790 Added 35.29%	2,506,293 $506 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $52.4 Million - $66.5 Million	266,004 Added 16.77%	1,852,503 $404 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $88 Million - $121 Million	482,207 Added 43.67%	1,586,499 $312 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $180 Million - $267 Million	883,029 Added 399.09%	1,104,292 $236 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $483,424 - $685,112	1,892 Added 0.86%	221,263 $62.8 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $847,879 - $1.08 Million	-2,413 Reduced 1.09%	219,371 $82.7 Million
Q3 2021 Nov 15, 2021	SELL	$372.64 - $458.3 $24.3 Million - $29.8 Million	-65,081 Reduced 22.69%	221,784 $91.5 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $11.7 Million - $14.7 Million	39,642 Added 16.03%	286,865 $106 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $4.9 Million - $5.88 Million	-19,630 Reduced 7.36%	247,223 $71.7 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $59.2 Million - $67.4 Million	266,853 New	266,853 $66.7 Million

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Charles River Laboratories International, Inc. Transaction History